star icon Benefits menu iconDashboard
See Price & Plans

Not registered yet? Get a free account.

Sign Up
search icon cancel icon

PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED

Leave site?

You're about to leave our website and go to an external link. Are you sure?

All Companies ›
West Bengal ›
Computer Related Services ›
PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED
Active
Updated: 03 Oct 2025

Probe International Clinical Research Private Limited, is an unlisted private company incorporated on 02 May, 2024. It is classified as a private limited company and is located in , . It's authorized share capital is INR 15.00 lac and the total paid-up capital is INR 15.00 lac.

The current status of Probe International Clinical Research Private Limited is - Active.

Read more

Subscription Plans

coin img Buy Dashboard using Credits

cancel img

Just a Quick Check!

This action will use 1 of your credits.

coins img Credits Balance: 0
Checkout other plans arrow img
Industry and products
Computer Related Services
Company size
Auth Capital
₹ 15.0 L
Paidup Capital
₹ 15.0 L
Revenue
Not Available
# Key metrics of Probe International Clinical Research - All rupee values in INR crores. Based on March 2025 numbers. | Metric | Value | Change | |---|---|---| | Auth Capital | ₹ 15.0 L | | | Paidup Capital | ₹ 15.0 L | | | Revenue | Not Available | | | Total Revenue | Details available with Tofler Pro subscription | -6.49% | | EBITDA | Details available with Tofler Pro subscription | -6.6% | | Net Profit | Details available with Tofler Pro subscription | 190.59% | | Networth | Details available with Tofler Pro subscription | -7.96% | | Borrowings | Details available with Tofler Pro subscription | 47.15% | | Assets | Details available with Tofler Pro subscription | 3.46% | | Gross Margin | Details available with Tofler Pro subscription | 0.27 | | Operating Margin | Details available with Tofler Pro subscription | -0.13 | | Net Profit Margin | Details available with Tofler Pro subscription | 7.03 | | Return on Equity | Details available with Tofler Pro subscription | 7.53 | | ROCE | Details available with Tofler Pro subscription | -2.41 | | Debt to Equity | Details available with Tofler Pro subscription | 0.18 |
Key Metrics

** All rupee values in INR crores.

Total Revenue
-6.49%
₹ GET PRO
EBITDA
-6.6%
₹ GET PRO
Net Profit
190.59%
₹ GET PRO
Networth
-7.96%
₹ GET PRO
Borrowings
47.15%
₹ GET PRO
Assets
3.46%
₹ GET PRO
Gross Margin
0.27
GET PRO %
Operating Margin
-0.13
GET PRO %
Net Profit Margin
7.03
GET PRO %
Return on Equity
7.53
GET PRO %
ROCE
-2.41
GET PRO %
Debt to Equity
0.18
GET PRO
Sales
Mar 2025
Net worth
Mar 2025

filter-square No Reports Available

filter-square

Tofler currently has no financial reports for this company due to a lack of available information. This may be because the company is dormant or closed (see company status) or because it was formed only recently (check the incorporation date) and financial data is not yet available.

You can view basic information by scrolling through the page.

* GST not included

** Reports & MCA filings will be based on the latest available financials.

** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.

coin imgChoose number of credits to buy

filter-square
1
plus icon minus icon

₹ 449 + GST

* INR 349 for 20+ credits purchase

1 credit = one company dashboard

Locations

indian flag India (1)
State Type Address

location icon Locations on Map

Map placeholder

filter-square Filter (4)

filter-square

Select Tags

Choose Location

People

Designation Name DIN/PAN Tenure
Director Amit Hazra 07734085 1 years
Director Subhrojyoti Bhowmick 09529279 1 years
Director Bijoy Das 08185301 2 years

Financial Highlights

** All numbers in INR crores
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Sales GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Gross margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin GET PRO GET PRO GET PRO GET PRO GET PRO
Networth
Borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Debt to equity GET PRO GET PRO GET PRO GET PRO GET PRO
Current ratio GET PRO GET PRO GET PRO GET PRO GET PRO
ROE GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
WC days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

₹
%
** All numbers in INR crores
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital GET PRO GET PRO GET PRO GET PRO GET PRO
Reserves GET PRO GET PRO GET PRO GET PRO GET PRO
Borrowings + GET PRO GET PRO GET PRO GET PRO GET PRO
Long term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Short term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Trade payables + GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
Other liabilities + GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Other current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Total liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Tangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
CWIP GET PRO GET PRO GET PRO GET PRO GET PRO
Intangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
LT loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Current assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Inventories GET PRO GET PRO GET PRO GET PRO GET PRO
Trade receivables GET PRO GET PRO GET PRO GET PRO GET PRO
Cash and cash equivalents GET PRO GET PRO GET PRO GET PRO GET PRO
ST loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total assets GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Total assets

Charges on assets

As per information available, the company has no registered charges.

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
HAMACARE PRIVATE LIMITED
Active
1.0 L 1 West Bengal
SPAECARE PRIVATE LIMITED
Active
1.0 L 1 West Bengal
PDX RESEARCH LABS LLP
Active
1.0 L 1 West Bengal
ARICA DIAGNOSTIC PRIVATE LIMITED
Active
3.3 L 1 West Bengal
SUNN EDUHEALTH CARE PRIVATE LIMITED
Active
1.0 L 1 West Bengal

Tofler Score

score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Registered Details

CIN

U72200WB2024PTC270356

PAN

-

Incorporation

2024, 1.6 years

Company Email

liptan.daltan@gmail.com

Paid up Capital

₹ 15.0 L

Authorised Capital

₹ 15.0 L

AGM

N.A.

Type

Private
Others

FAQ - PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED

What is the incorporation date of PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED?

plus icon

The incorporation date of PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED is 02 May, 2024

What is the authorized share capital of PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED?

plus icon

The authorized share capital of PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED is INR ₹ 15.0 L.

What is the paid-up capital of PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED?

plus icon

The paid-up capital of PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED is INR ₹ 15.0 L.

What is the registered address of PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED?

plus icon

The registered address of PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED is UNIT-608, BLOCK-1, QUBE, AA-II, New Town, North 24 Parganas, New Town, West Bengal, India, 700156 - 700156

What is the CIN number of PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED?

plus icon

The CIN number of PROBE INTERNATIONAL CLINICAL RESEARCH PRIVATE LIMITED is U72200WB2024PTC270356.

Smart Suggestions

  • Top Blog Post
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More